Sofosbuvir
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Sofosbuvir and local guidelines before prescribing.
Direct-acting antiviral (HCV)
Mechanism
NS5B polymerase inhibitor (nucleotide analogue).
Uses
Chronic hepatitis C (combination regimens).
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Fatigue, headache, nausea, bradycardia with amiodarone.
Interactions
Amiodarone (severe bradycardia), rifampicin and St John's wort reduce levels.
Contraindications and cautions
Concurrent amiodarone
Monitoring
HCV RNA, HBV markers
Pregnancy and breastfeeding
Avoid with ribavirin
Renal and hepatic impairment
Limited data in severe renal impairment
Overdose and reversal
Supportive
Special advice
Check HBV status before starting; avoid amiodarone.
More from the textbook: uses, cautions and other points
- Hepatitis C - direct-acting antivirals (e.g. sofosbuvir-based combinations, glecaprevir–pibrentasvir) for 8–12 weeks cure over 95%; check interactions (sofosbuvir with amiodarone - severe bradycardia; enzyme inducers; PPIs with some regimens) and check for hepatitis B (reactivation risk).
Gastroenterology: Anatomy Physiology Pharmacology - Check drug interactions (e.g. amiodarone with sofosbuvir - severe bradycardia; some statins, antiepileptics and the pill). Check hepatitis B status - HBV can reactivate during treatment.
Gastroenterology: Liver disease - Sofosbuvir/velpatasvir (12 weeks) or glecaprevir/pibrentasvir (8 weeks) | Hepatitis C cure over 95%; check interactions (amiodarone) and HBV status.
Gastroenterology: Liver disease - Pangenotypic tablets for 8–12 weeks (e.g. sofosbuvir–velpatasvir, glecaprevir–pibrentasvir) - over 95% cure with few side effects.
ID: HIV, viral hepatitis and blood-borne viruses - Interactions - sofosbuvir with amiodarone (severe bradycardia - avoid), PPIs and antacids (reduce some DAAs), enzyme inducers (carbamazepine, phenytoin, rifampicin, St John's wort - contraindicated), statins, ethinylestradiol with some regimens (liver enzyme rises) - check the Liverpool hepatitis interaction checker.
ID: HIV, viral hepatitis and blood-borne viruses - Bradycardia after starting hepatitis C treatment on amiodarone | Sofosbuvir–amiodarone interaction
ID: HIV, viral hepatitis and blood-borne viruses - Hepatitis C is curable in 8–12 weeks; avoid sofosbuvir with amiodarone.
ID: HIV, viral hepatitis and blood-borne viruses - Sofosbuvir/velpatasvir (12 weeks).
Gastroenterology: Liver disease